Showing results (71-80 of 136) with videos related to
Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugateNicole M Okeley, Jamie B Miyamoto, Xinqun Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disordersMadeleine Duvic, Sunil A Reddy, Lauren Pinter-Brown, et al.Atherosclerosis|November 3, 2009
The separate and joint effects of prolonged QT interval and heart rate on mortalityNan Hee Kim, Meda E Pavkov, Robert G Nelson, et al.Journal of Virology|January 16, 2024
"Smart markets": harnessing the potential of new technologies for endemic and emerging infectious disease surveillance in traditional food marketsBenjamin L Sievers, Jurre Y Siegers, Jimmy M Cadènes, et al.Journal of Diabetes and Its Complications|November 7, 2017
Serum lipids and mortality in an American Indian population: A longitudinal studyStephanie K Tanamas, Pierre-Jean Saulnier, Robert L Hanson, et al.Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.Journal of Medical Case Reports|March 3, 2025
Tracheal nodularity and paratracheal soft tissue nodule: post-radioactive iodine treatment changes with peculiar visual and pathologic findings in a case of metastatic follicular variant papillary thyroid carcinoma: a case reportBenjamin L Sievers, Wangpan Shi, Jingjing Hu, et al.Clinical Trials (London, England)|May 8, 2016
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial settingAjay K Gopal, Barbara Pro, Joseph M Connors, et al.Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
A phase I weekly dosing study of brentuximab vedotin in patients with relapsed/refractory CD30-positive hematologic malignanciesMichelle A Fanale, Andres Forero-Torres, Joseph D Rosenblatt, et al.Pageof 14